UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

The Journal of pharmacology and experimental therapeutics, 1997-01, Vol.280 (1), p.83

1997

Volltextzugriff (PDF)

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

The Journal of pharmacology and experimental therapeutics, 1997-01, Vol.280 (1), p.73

1997

Volltextzugriff (PDF)

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

The Journal of pharmacology and experimental therapeutics, 2002-06, Vol.301 (3), p.1067-1078

2002

Volltextzugriff (PDF)

Effects of the β3 -adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

Neuroscience, 2008-10, Vol.156 (2), p.353-364

2008

Volltextzugriff (PDF)

The NMDA receptor complex

Fundamental & clinical pharmacology, 1993-01, Vol.7 (8), p.389-400

Scatton, B.

1993

Volltextzugriff (PDF)

Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse

European journal of pharmacology, 1991-11, Vol.204 (3), p.339-340

1991

Volltextzugriff (PDF)

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

The Journal of pharmacology and experimental therapeutics, 2003-07, Vol.306 (1), p.407-420

2003

Volltextzugriff (PDF)

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

Biological psychiatry (1969), 2005-02, Vol.57 (3), p.261-267

2005

Volltextzugriff (PDF)

Excitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases

Life sciences (1973), 1994, Vol.55 (25), p.2115-2124

Scatton, B.

1994

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (9), p.6370-6375

2002

Volltextzugriff (PDF)

The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Cell Proliferation and Increases Markers of Adipocyte Maturation in Cultured Mouse 3T3 F442A Preadipocytes

Molecular pharmacology, 2006-02, Vol.69 (2), p.471-478

2006

Volltextzugriff (PDF)

New perspectives for the treatment of disorders of sleep and arousal

Annales pharmaceutiques françaises, 2007-07, Vol.65 (4), p.268-274

2007

Volltextzugriff (PDF)

SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile

The Journal of pharmacology and experimental therapeutics, 2004-09, Vol.310 (3), p.1171

2004

Volltextzugriff (PDF)

Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin

Molecular pharmacology, 1995-06, Vol.47 (6), p.1189-1196

1995

Volltextzugriff (PDF)

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

Psychopharmacologia, 2005-08, Vol.181 (1), p.134-144

2005

Volltextzugriff (PDF)

Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex

The Journal of pharmacology and experimental therapeutics, 1990-05, Vol.253 (2), p.475

1990

Volltextzugriff (PDF)

S37 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF FEEDING BEHAVIOUR AND BODY WEIGHT: PHARMACOLOGICAL EFFECTS OF RIMONABANT, A CB1 CANNABINOID RECEPTOR ANTAGONIST

Behavioural pharmacology, 2005-09, Vol.16 (Supplement 1), p.S12-S13

2005

Volltextzugriff (PDF)

Pharmacological and molecular targets in the search for novel antipsychotics

Behavioural pharmacology, 2000-06, Vol.11 (3 & 4), p.243-256

2000

Volltextzugriff (PDF)

Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐d‐Aspartate Receptor Activation In Vivo

Journal of neurochemistry, 1992-06, Vol.58 (6), p.2170-2175

1992

Volltextzugriff (PDF)

Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem

Brain research, 1993-02, Vol.604 (1), p.240-250

1993

Volltextzugriff (PDF)

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window

Brain research, 1993-08, Vol.620 (1), p.32-41

1993

Volltextzugriff (PDF)

Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission

Life sciences (1973), 1982-12, Vol.31 (25), p.2883-2890

Scatton, B

1982

Volltextzugriff (PDF)

Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity

The Journal of pharmacology and experimental therapeutics, 1982-01, Vol.220 (1), p.197

Scatton, B

1982

Volltextzugriff (PDF)

Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors

Neuroscience, 1986-09, Vol.19 (1), p.125-137

1986

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(446)
Mit Volltextzugriff
(365)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(229)
Rats
(213)
Science & Technology
(212)
Life Sciences & Biomedicine
(208)
Male
(196)
Biological And Medical Sciences
(158)
Neurosciences & Neurology
(110)
Neurosciences
(105)
Rats, Inbred Strains
(104)
Humans
(97)
Medical Sciences
(91)
Pharmacology & Pharmacy
(75)
Fundamental And Applied Biological Sciences. Psychology
(69)
Pharmacology. Drug Treatments
(67)
Vertebrates: Nervous System And Sense Organs
(60)
Neuropharmacology
(57)
Central Nervous System
(56)
Brain - Metabolism
(53)
Female
(46)
Corpus Striatum - Metabolism
(45)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity

Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair

Effects of the β3 -adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile

The NMDA receptor complex

Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse

SSR591813, a Novel Selective and Partial α 4 β 2 Nicotinic Receptor Agonist with Potential as an Aid to Smoking Cessation

Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents

Excitatory amino acid receptor antagonists: A novel treatment for ischemic cerebrovascular diseases

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V 1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders

The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Cell Proliferation and Increases Markers of Adipocyte Maturation in Cultured Mouse 3T3 F442A Preadipocytes

New perspectives for the treatment of disorders of sleep and arousal

SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile

Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin

SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist, alleviates disturbances of novelty discrimination in a social context in rats, a putative model of selective attention deficit

Ifenprodil and SL 82.0715 as cerebral antiischemic agents. III. Evidence for antagonistic effects at the polyamine modulatory site within the N-methyl-D-aspartate receptor complex

S37 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF FEEDING BEHAVIOUR AND BODY WEIGHT: PHARMACOLOGICAL EFFECTS OF RIMONABANT, A CB1 CANNABINOID RECEPTOR ANTAGONIST

Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-I SSR504734, a potential new type of antipsychotic

Pharmacological and molecular targets in the search for novel antipsychotics

Selective Release of Spermine and Spermidine from the Rat Striatum by N‐Methyl‐d‐Aspartate Receptor Activation In Vivo

Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window

Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission

Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity

Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors

Suchergebnisse filtern